Table 2 Comparison of key characteristics of the 5 cancer-related identities
Someone who has had cancer n = 1468 (%) | Patient n = 882 (%) | Cancer survivor n = 561 (%) | Cancer conqueror n = 364 (%) | Victim n = 72 (%) | |
|---|---|---|---|---|---|
Age at survey (years)** | |||||
≤ 70 | 12.7 | 10.2 | 7.8 | 13.2 | 9.7 |
> 70 ≤ 80 | 49.4 | 48.2 | 43.5 | 45.9 | 52.8 |
> 80 | 37.9 | 41.6 | 48.7 | 40.9 | 37.5 |
Educational level** | |||||
primary, secondary - low | 36.3 | 38.8 | 46.0 | 45.1 | 52.5 |
secondary - intermediate | 17.9 | 17.3 | 15.4 | 19.0 | 16.4 |
secondary - high | 12.5 | 11.9 | 12.8 | 10.2 | 13.1 |
tertiary | 33.3 | 32.0 | 25.8 | 25.7 | 18.0 |
Partnership | |||||
yes | 92.2 | 91.9 | 90.7 | 95.0 | 91.4 |
no | 7.8 | 8.1 | 9.3 | 5.0 | 8.6 |
Children | |||||
0 | 12.1 | 12.8 | 9.3 | 9.9 | 8.5 |
≥ 1 | 87.9 | 87.2 | 90.7 | 90.1 | 91.5 |
Age at surgery (years) | |||||
≤ 55 | 13.8 | 10.0 | 8.9 | 13.5 | 12.5 |
> 55 ≤ 65 | 52.1 | 51.7 | 51.7 | 52.7 | 55.6 |
> 65 | 34.1 | 38.3 | 39.4 | 33.8 | 31.9 |
Time since surgery (years)*** | |||||
≤ 10 | 5.7 | 6.8 | 5.5 | 5.8 | 4.2 |
> 10 ≤ 15 | 44.3 | 42.2 | 36.0 | 46.4 | 43.0 |
> 15 ≤ 20 | 40.7 | 40.8 | 41.7 | 34.9 | 41.7 |
> 20 | 9.3 | 10.2 | 16.8 | 12.9 | 11.1 |
Second primary cancer | |||||
yes | 11.7 | 12.5 | 15.5 | 13.7 | 16.7 |
no | 88.3 | 87.5 | 84.5 | 86.3 | 83.3 |
Family history of PCa | |||||
yes | 40.5 | 35.9 | 38.2 | 40.4 | 33.3 |
no | 59.5 | 64.1 | 61.8 | 59.6 | 66.7 |
Biochemical recurrence during FU**** | |||||
yes | 31.6 | 49.1 | 51.3 | 39.6 | 54.1 |
no | 68.4 | 50.9 | 48.7 | 60.4 | 45.9 |
Biochemical recurrence at survey**** | |||||
yes | 13.7 | 29.6 | 21.9 | 16.8 | 25.9 |
no | 86.3 | 70.4 | 78.1 | 83.2 | 74.1 |
Discontinued PSA follow-up | |||||
yes | 5.3 | 5.1 | 6.6 | 5.5 | 9.7 |
no | 94.7 | 94.9 | 93.4 | 94.5 | 90.3 |
Ongoing treatment at survey**** | |||||
yes | 6.2 | 19.7 | 18.3 | 13.0 | 23.2 |
no | 93.8 | 80.3 | 81.7 | 87.0 | 76.8 |
PHQ-2 (depression screening) **** | |||||
positive screening (≥3) | 12.0 | 15.0 | 19.7 | 13.0 | 39.1 |
negative screening (< 3) | 88.0 | 85.0 | 80.3 | 87.0 | 60.9 |
GAD-2 (anxiety disorder screening) **** | |||||
positive screening (≥3) | 9.7 | 10.2 | 16.2 | 8.7 | 37.3 |
negative screening (< 3) | 90.3 | 89.8 | 83.8 | 91.3 | 62.7 |
Perceived severity of disease**** | |||||
low | 48.4 | 50.6 | 31.1 | 44.5 | 18.8 |
high | 51.6 | 49.4 | 68.9 | 55.5 | 82.2 |
Well-being**** | |||||
low | 32.3 | 34.5 | 41.0 | 24.8 | 65.2 |
high | 67.7 | 65.5 | 59.0 | 75.2 | 34.8 |
Benefit finding**** | |||||
low | 59.6 | 60.6 | 43.9 | 48.6 | 58.6 |
high | 30.4 | 39.4 | 56.1 | 51.4 | 41.4 |